Gupta AK - Search Results

1

Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations.

Brunner TB, Hahn SM, Gupta AK, Muschel RJ, McKenna WG, Bernhard EJ. Brunner TB, et al. Among authors: gupta ak. Cancer Res. 2003 Sep 15;63(18):5656-68. Cancer Res. 2003. PMID: 14522880 Review.

2

Signaling inhibition with radiation in colorectal cancer: clinical trials.

McKenna WG, Muschel RJ, Gupta A, Hahn S, Bernhard EJ. McKenna WG, et al. Semin Oncol. 2003 Jun;30(3 Suppl 6):56-67. doi: 10.1016/s0093-7754(03)00126-x. Semin Oncol. 2003. PMID: 12802796 Review.

3

Farnesyltransferase inhibitors as radiation sensitizers.

McKenna WG, Muschel RJ, Gupta AK, Hahn SM, Bernhard EJ. McKenna WG, et al. Among authors: gupta ak. Semin Radiat Oncol. 2002 Jul;12(3 Suppl 2):27-32. doi: 10.1053/srao.2002.34866. Semin Radiat Oncol. 2002. PMID: 12174342 Review.

4

A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer.

Martin NE, Brunner TB, Kiel KD, DeLaney TF, Regine WF, Mohiuddin M, Rosato EF, Haller DG, Stevenson JP, Smith D, Pramanik B, Tepper J, Tanaka WK, Morrison B, Deutsch P, Gupta AK, Muschel RJ, McKenna WG, Bernhard EJ, Hahn SM. Martin NE, et al. Among authors: gupta ak. Clin Cancer Res. 2004 Aug 15;10(16):5447-54. doi: 10.1158/1078-0432.CCR-04-0248. Clin Cancer Res. 2004. PMID: 15328183 Clinical Trial.

5

HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo.

Gupta AK, Cerniglia GJ, Mick R, McKenna WG, Muschel RJ. Gupta AK, et al. Cancer Res. 2005 Sep 15;65(18):8256-65. doi: 10.1158/0008-5472.CAN-05-1220. Cancer Res. 2005. PMID: 16166302

6

Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir.

Jiang Z, Pore N, Cerniglia GJ, Mick R, Georgescu MM, Bernhard EJ, Hahn SM, Gupta AK, Maity A. Jiang Z, et al. Among authors: gupta ak. Cancer Res. 2007 May 1;67(9):4467-73. doi: 10.1158/0008-5472.CAN-06-3398. Cancer Res. 2007. PMID: 17483362

7

Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines.

Bernhard EJ, Stanbridge EJ, Gupta S, Gupta AK, Soto D, Bakanauskas VJ, Cerniglia GJ, Muschel RJ, McKenna WG. Bernhard EJ, et al. Among authors: gupta s, gupta ak. Cancer Res. 2000 Dec 1;60(23):6597-600. Cancer Res. 2000. PMID: 11118040

8

The Ras radiation resistance pathway.

Gupta AK, Bakanauskas VJ, Cerniglia GJ, Cheng Y, Bernhard EJ, Muschel RJ, McKenna WG. Gupta AK, et al. Cancer Res. 2001 May 15;61(10):4278-82. Cancer Res. 2001. PMID: 11358856

9

Farnesyltransferase inhibitors as radiation sensitizers.

Brunner TB, Gupta AK, Shi Y, Hahn SM, Muschel RJ, McKenna WG, Bernhard EJ. Brunner TB, et al. Among authors: gupta ak. Int J Radiat Biol. 2003 Jul;79(7):569-76. doi: 10.1080/09553000310001610196. Int J Radiat Biol. 2003. PMID: 14530152 Review.

10

Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.

Gupta AK, McKenna WG, Weber CN, Feldman MD, Goldsmith JD, Mick R, Machtay M, Rosenthal DI, Bakanauskas VJ, Cerniglia GJ, Bernhard EJ, Weber RS, Muschel RJ. Gupta AK, et al. Clin Cancer Res. 2002 Mar;8(3):885-92. Clin Cancer Res. 2002. PMID: 11895923 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,800 results

Search Page

Filters